Navigation Links
Access Pharmaceuticals Signs eMarketing Agreement With iMedicor For MuGard(TM)
Date:10/6/2009

DALLAS, Oct. 6 /PRNewswire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP) announced today that it had signed an agreement with iMedicor (OTC Bulletin Board: VMCI) for the North American commercial launch of MuGard, its FDA approved mucoadhesive oral rinse for the management of oral mucositis and stomatitis caused by radiotherapy and/or chemotherapy. Using iMedicor's highly targeted Alerts System application, initial introduction of MuGard to the 216,000 selected physicians in the US is expected to begin by the end of the year. MuGard is being commercially launched worldwide, with initial launches in the United Kingdom, Germany, Italy, Norway and Greece having been previously announced. Access expects additional commercial launches in Europe, and in the Far East through two partners to start shortly.

"We look forward to working with Access Pharma to help them introduce MuGard in a cost effective, non-intrusive manner, a potential blockbuster product which could significantly improve the quality of life for patients undergoing certain cancer treatments," said Fred Zolla, CEO of Vemics iMedicor. "Using our Alert System, iMedicor's ability to deliver essential information from a trusted source to specific physician audiences will significantly increase our client's marketing ROI."

MuGard is a novel, ready-to-use mucoadhesive oral wound rinse for the management of oral mucositis, a debilitating side effect of many anticancer treatments. Up to 80% of all patients receiving radiotherapy and approximately 40% of all chemotherapy patients develop oral mucositis, and almost all patients receiving radiotherapy for head and neck cancer and those undergoing stem cell transplantation develop mucositis. Updated clinical practice guidelines for the prevention and treatment of mucositis recommend
'/>"/>

SOURCE Access Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. ShowerBuddy - Affordable, Accessible Bathing
2. Access Pharmaceuticals Provides Update on ProLindac Clinical Development Program
3. Why Do African-Americans Fare Worse With Cancer? Access and Economics Are Only Part of the Story
4. Access Pharmaceuticals Announces Publication of Thiarabine Combination Data
5. Access Pharmaceuticals Announces Positive ProLindac(TM) Phase 2 Ovarian Cancer Clinical Trial Results
6. Access Licenses ProLindac(TM) and MuGard(TM) to JCOM Ltd, an Affiliate of DONG-A Pharmaceuticals in Korea
7. First U.S. Patients Enrolled in the REALISM Continued Access Study
8. Access Pharmaceuticals Presents new Combination Data on the Companys Angiolix(R) Therapeutic Monoclonal Antibody
9. Wrist Access Safer, Easier for Many Patients Undergoing Minimally Invasive Treatment of Blocked Heart Arteries
10. Access Pharmaceuticals Presents New Data on the Companys Angiolix(R) Therapeutic Monoclonal Antibody
11. Unprecedented 8th Year Start Up of National Direct AmeriCorps Program Access to Care Through Service (ACTS) Parent, Lead Organization The Philadelphia AIDS Consortium and World Health Care Infrastructures
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... England , July 22, 2014 ... development and device company focused on solid dose ... its novel solid formulation of octreotide acetate achieved ... it with the currently marketed liquid product (Sandostatin®). ... transfer the formulation production process to a contract ...
(Date:7/21/2014)... /PRNewswire-iReach/ -- Nitrosolution.com, a website that features safe and ... first anniversary in August. The online retailer specializes in ... body,s ability to produce nitric oxide. Called Nitroxyl, it ... a variety of phytonutrients and other natural ingredients that ... nitric oxide production in the arteries and ...
(Date:7/21/2014)... , July 21, 2014 Thoratec Corporation (NASDAQ: ... mechanical circulatory support therapies to save, support and restore ... operating results for the second quarter of fiscal year ... will hold a conference call to discuss its financial ... at 1:30 p.m., Pacific Daylight Time (4:30 p.m., Eastern ...
Breaking Medicine Technology:Glide Pharma Completes Successful Proof-of-Concept Study with Novel Solid Dose Formulation of Octreotide 2Up and Coming Nitric Oxide Supplements Company Nitrosolution.com Celebrates its One Year Anniversary 2Thoratec Schedules Second Quarter Conference Call, Webcast 2
... 12 Lexicon,Pharmaceuticals, Inc. (Nasdaq: LXRX ) ... drug (IND) application to the U.S. Food and ... for rheumatoid,arthritis and other autoimmune conditions. The initial ... a double-blind, randomized,placebo-controlled, ascending single-dose study in healthy ...
... Medical Lasers Limited,(ASX: ELX), a global leader in ... systems, announced today initial clinical results of,an ongoing ... demonstrate the therapy,s potential to improve and,stabilize visual ... with,diabetic maculopathy and macular edema without causing any ...
Cached Medicine Technology:Lexicon Files Investigational New Drug Application for LX2931 as a Potential Treatment for Rheumatoid Arthritis 2Lexicon Files Investigational New Drug Application for LX2931 as a Potential Treatment for Rheumatoid Arthritis 3Ellex 2RT Study Demonstrates Clinical Efficacy in Treatment of Diabetic Macular Edema 2Ellex 2RT Study Demonstrates Clinical Efficacy in Treatment of Diabetic Macular Edema 3Ellex 2RT Study Demonstrates Clinical Efficacy in Treatment of Diabetic Macular Edema 4
(Date:7/22/2014)... One of the largest studies ever conducted into the ... new sites on chromosomes that harbor inherited genes tied ... team of researchers, now bring the total number of ... Although these schizophrenia-associated genes aren,t specific enough ... will or will not develop the illness, researchers say ...
(Date:7/22/2014)... July 22, 2014 CarePoint Health is pleased ... as the President of the medical staff at Bayonne Medical ... serve as President, as voted on by the physicians on ... medical staff in relation to the administration at Bayonne Medical ... physicians and to work to make the Medical Center the ...
(Date:7/22/2014)... The donation from the Edusei Foundation was greatly ... a feat of strategic engineering, such assistance tends to etch ... the beneficiaries. It provided a sense of family to them, ... Edusei Foundation donated various amounts of; milk, soap, ... , The Government of Ghana established the Kumasi Children’s Home ...
(Date:7/22/2014)... 2014 Hospitals & Health ... conducted by Hospitals & Health Networks in ... CareTech Solutions, The College of Healthcare Information ... list recognizes hospitals for successful health information ... in four focus areas: business and administrative ...
(Date:7/22/2014)... TUESDAY, July 22, 2014 (HealthDay News) -- People who ... risk for a rise in blood pressure, a new ... major health problems and even early death, but few ... trouble may be one of the causes, according to ... 138 people who had been separated or divorced for ...
Breaking Medicine News(10 mins):Health News:Gene Discoveries Could Shed New Light on Schizophrenia 2Health News:Dr. Howard Levine Elected President of the Medical Staff at Bayonne Medical Center 2Health News:Edusei Foundation Donates Food and Needed Items to Kumasi Children’s Home in Ashanti Region of Ghana 2Health News:Healthline Systems’ Clients Honored Among Most Wired for 2014 2Health News:Healthline Systems’ Clients Honored Among Most Wired for 2014 3Health News:Healthline Systems’ Clients Honored Among Most Wired for 2014 4Health News:Sleepless Nights After Divorce May Be Tied to Blood Pressure Rise 2
... The Association for Research in Vision and Ophthalmology ... distinguished fellows. The title of Fellow of ARVO (FARVO) ... the Association. By accepting this honor, ARVO anticipates ... and mentors for individuals pursuing careers in vision and ...
... be important in cardiac development has been newly associated ... the left ventricular outflow tract. These are the findings ... appearing in the journal Birth Defects Research Part ... including aortic valve stenosis, coarctation of the aorta, hypoplastic ...
... tomography (PET) in patients with head and neck tumours, ... cannot currently be reliably assessed. This is the result ... for Quality and Efficiency in Health Care (IQWiG). The ... to assess the advantages and disadvantages of this diagnostic ...
... prostate-rectal inter-space is an effective way to reduce the ... according to research presented April 30, 2011, at the ... symposium is sponsored by the American Society for Radiation ... Even though prostate cancer is cured in over 90 ...
... Combining computerized tomography (CT) with fluorodeoxyglucose positron emission ... tumor outlines and potentially different treatment options in ... CT alone, according to research presented today, at ... Atlanta. This symposium is co-sponsored by the American ...
... of hospitalization have discouraged primary care doctors from seeing ... use of "hospitalists," a new physician specialty focused on ... field mean that frequently hospitalized patients also may need ... expert on hospital care at the University of Chicago. ...
Cached Medicine News:Health News:2011 ARVO Fellows announced 2Health News:Study identifies second gene associated with specific congenital heart defects 2Health News:Benefit of PET in patients with head and neck tumors cannot be assessed 2Health News:Benefit of PET in patients with head and neck tumors cannot be assessed 3Health News:Benefit of PET in patients with head and neck tumors cannot be assessed 4Health News:Tissue spacers reduce risk of rectal injury for prostate cancer patients 2Health News:Frequently hospitalized patients may benefit from new medical specialty focused on their needs 2
... Auto Suture™ POLY GIA™ 75-.060 single ... staggered rows of LACTOMER™ absorbable copolymer ... between the two, double rows., ... single use surgical stapler has application ...
... ILA™ 75 single-use stapler, anastomotic type, ... resection, transection, and/or the anastomosis of ... The ILA™ 75 single-use stapler, anastomotic ... the resection, transection, and/or the anastomosis ...
... The PROXIMATE ILS Staplers are anastomotic ... proper matching of instrument to lumen diameter. ... detachable anvil head to improve access and ... surgeon to control tissue compression by adjusting ...
... Use Biofragmentable Anastomosis Rings., ... side-to-side anastomosis., ,VALTRAC™ Ring is ... anastomoses but not for gastric and ... used in any disease process for ...
Medicine Products: